Eam Investors, LLC Emergent Bio Solutions Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$79.17 - $111.47 $1.35 Million - $1.9 Million	-17,047 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $1.4 Million - $2.3 Million	17,047 New	17,047 $1.76 Million
Q1 2019 May 13, 2019	SELL	$48.23 - $66.16 $1.58 Million - $2.17 Million	-32,808 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$55.63 - $73.24 $1.26 Million - $1.66 Million	-22,715 Reduced 40.91%	32,808 $1.95 Million
Q3 2018 Nov 08, 2018	BUY	$52.05 - $66.51 $2.89 Million - $3.69 Million	55,523 New	55,523 $3.66 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.